Lipemia retinalis associated with branch retinal vein occlusion

Triglycerides and Cardiovascular Disease

“…Even when a secondary cause is identified, family screening to uncover a genetic lipid disorder is also in order. 357 In addition to pancreatitis, other potentially adverse clinical manifestations of chylomicronemia include retinal thrombosis 358 and, in rare cases, blindness. Therefore, very high triglyceride levels often require both therapeutic lifestyle change and pharmacological therapy as outlined in ATP III.…”

Branch Retinal Vein Occlusion

“…Over the recent years, there have been a number of anecdotal case reports of BRVO with many systemic diseases, including Bartonella [ 17 ], Behcet's disease [ 18 , 19 ], Coats' disease [ 20 ], Crohn's disease [ 21 ], deep-sea diving [ 22 ], Eales' disease [ 23 ], focal retinal phlebitis [ 24 ], high altitude [ 25 ], human immunodefi ciency virus [ 26 , 27 ], infl iximab treatment [ 28 ], interferon therapy [ 29 ], lipemia retinalis [ 30 ], during fi ngolimod treatment of multiple sclerosis [ 31 ], ocular candidiasis [ 32 ], ocular Lyme borreliosis [ 33 ], ocular tuberculosis [ 34 ], primary intraocular lymphoma [ 35 ], pseudoexfoliation [ 36 , 37 ], quetiapine fumarate [ 38 ], sarcoidosis [ 39 -42 ], superior ophthalmic vein thrombosis [ 43 ], systemic lupus erythematosus [ 44 ], Takayasu's arteritis [ 45 ], tamoxifen [ 46 ], toxoplasmic chorioretinitis [ 47 ], Tsutsugamushi disease [ 48 ], and Waardenburg syndrome [ 49 ]. As discussed above, the association of a condition with a systemic disease does not always mean cause and effect.…”

Exceptionally elevated triglyceride in severe lipemia retinalis

“…Markedly elevated TG in lipemia retinalis might predispose patients to develop potential ocular complications caused by the inner retinal ischemia 14. Although the literature has shown that fundus lesions of lipemia retinalis might be resolved after appropriate treatment,4–6,9 it remains unknown whether future retinal function and vision development may be impaired in sHTG infants.…”